Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, January 18, 2023
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
Liisa Bayko Maintained (ALT) at Buy with Increased Target to $25 on, Jan 18th, 2023
Liisa Bayko of Evercore ISI Group, Maintained "Altimmune, Inc." (ALT) at Buy with Increased Target from $14 to $25 on, Jan 18th, 2023.
Liisa has made no other calls on ALT in the last 4 months.
There are 2 other peers that have a rating on ALT. Out of the 2 peers that are also analyzing ALT, 0 agree with Liisa's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Liisa
- Corinne Jenkins of "Goldman Sachs" Initiated at Strong Buy and Held Target at $20 on, Thursday, December 1st, 2022
- Jonathan Wolleben of "JMP Securities" Maintained at Buy with Decreased Target to $26 on, Friday, November 11th, 2022
